Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-YL)-3,4-dihydroxy… Grant US-9718853-B2 United States of America 01 Aug 2017
Combination, kit and method of reducing intraocular pressure Grant US-9370530-B2 United States of America 21 Jun 2016
Method of reducing intraocular pressure in humans Grant US-9289383-B2 United States of America 22 Mar 2016
Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxy… Grant US-9278991-B2 United States of America 08 Mar 2016
Purine derivatives as adenosine A1 receptor agonists and methods of use thereof Grant US-8609833-B2 United States of America 17 Dec 2013
Purine derivatives as adenosine A1 receptor agonists and methods of use thereof Grant US-8183224-B2 United States of America 22 May 2012
Purine derivatives and methods of use thereof Grant US-8133880-B2 United States of America 13 Mar 2012
Purine Derivatives and methods of use thereof Grant US-7863253-B2 United States of America 04 Jan 2011
Purine derivatives and methods of use thereof Grant US-7732424-B2 United States of America 08 Jun 2010
Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof Grant US-7423144-B2 United States of America 09 Sep 2008
PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION AND ENDOTOXIN-RELATED INJURY USING… Application EP-0755254-A4 European Patent Office 16 Jan 2002
PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION AND ENDOTOXIN-RELATED INJURY USING… Application EP-0755254-A1 European Patent Office 29 Jan 1997